ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

Adjuvant Nutrition Breast Cancer Study Offered To Groups

March 19, 1982

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999